These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35476943)

  • 1. Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms: A Markov Model-Based Cost-Effectiveness Analysis.
    Rink JS; Froelich MF; McWilliams JP; Gratzke C; Huber T; Gresser E; Schoenberg SO; Diehl SJ; Nörenberg D
    J Am Coll Radiol; 2022 Jun; 19(6):733-743. PubMed ID: 35476943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Utility Analysis of Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms.
    Capdevila F; Insausti I; San Miguel R; Sanchez-Iriso E; Montesino M
    Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1025-1035. PubMed ID: 37142802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(6):1-139. PubMed ID: 34188733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.
    Wu X; Zhou A; Heller M; Kohlbrenner R
    J Vasc Interv Radiol; 2022 Dec; 33(12):1605-1615. PubMed ID: 35964881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial.
    Abt D; Müllhaupt G; Hechelhammer L; Markart S; Güsewell S; Schmid HP; Mordasini L; Engeler DS
    Eur Urol; 2021 Jul; 80(1):34-42. PubMed ID: 33612376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.
    Carnevale FC; Iscaife A; Yoshinaga EM; Moreira AM; Antunes AA; Srougi M
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):44-52. PubMed ID: 26506952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing prostatic artery embolization to surgical and minimally invasive procedures for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis.
    Altman R; Ferreira R; Barragan C; Bhojani N; Lajkosz K; Zorn KC; Chughtai B; Annamalai G; Elterman DS
    BMC Urol; 2024 Jan; 24(1):22. PubMed ID: 38281906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study.
    Vigneswaran G; Maclean D; Hadi M; Maher B; Modi S; Bryant T; Harris M; Hacking N
    Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1095-1102. PubMed ID: 33825062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial.
    Kristensen-Alvarez A; Fode M; Stroomberg HV; Nielsen KK; Arch A; Lönn LB; Taudorf M; Widecrantz SJ; Røder A
    Trials; 2024 Sep; 25(1):574. PubMed ID: 39223593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.
    Raizenne BL; Zheng X; Oumedjbeur K; Mao J; Zorn KC; Elterman D; Bhojani N; McClure T; Te A; Kaplan S; Sedrakyan A; Chughtai B
    World J Urol; 2023 Jan; 41(1):179-188. PubMed ID: 36463348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Minimally Invasive Procedures for Benign Prostatic Hyperplasia: A Cost-effectiveness Analysis.
    Wu X; Zhou A; Heller M; Chi T; Kohlbrenner R
    Radiology; 2023 Dec; 309(3):e230555. PubMed ID: 38085076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis.
    Jiang YL; Qian LJ
    BMC Urol; 2019 Jan; 19(1):11. PubMed ID: 30691478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.
    Abt D; Hechelhammer L; Müllhaupt G; Markart S; Güsewell S; Kessler TM; Schmid HP; Engeler DS; Mordasini L
    BMJ; 2018 Jun; 361():k2338. PubMed ID: 29921613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
    Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
    J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of prostatic urethral lift vs prostatic artery embolization for benign prostatic hyperplasia: a systematic review and network meta-analysis.
    Lucas-Cava V; Sánchez-Margallo FM; Insausti-Gorbea I; Sun F
    BJU Int; 2023 Feb; 131(2):139-152. PubMed ID: 35417622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic Artery Embolization for the Treatment of Recurrent Lower Urinary Tract Symptoms following Transurethral Resection of the Prostate.
    Xu ZW; Tian W; Zhou CG; Leng B; Shi HB; Liu S
    J Vasc Interv Radiol; 2021 Feb; 32(2):242-246. PubMed ID: 33248915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.